Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bryant

Showing results (511-520 of 548) with videos related to

Pageof 55
Sort By:
Genes, Brain, and Behavior|October 22, 2021
A quantitative trait variant in Gabra2 underlies increased methamphetamine stimulant sensitivityLisa R Goldberg, Emily J Yao, Julia C Kelliher, et al.
G3 (Bethesda, Md.)|July 21, 2019
<i>Cyfip1</i> Haploinsufficiency Increases Compulsive-Like Behavior and Modulates Palatable Food Intake in Mice: Dependence on <i>Cyfip2</i> Genetic Background, Parent-of Origin, and SexRichard K Babbs, Jacob A Beierle, Qiu T Ruan, et al.
Cell Biology and Toxicology|April 24, 2023
GABA<sub>A</sub> receptor-mediated seizure liabilities: a mixed-methods screening approachKonstantina Bampali, Filip Koniuszewski, Florian D Vogel, et al.
Pilot and Feasibility Studies|May 15, 2025
Results of a feasibility study of the FReSH START intervention to improve quality of life and other outcomes in people who repeatedly self-harm (Function REplacement in repeated Self-Harm: Standardising Therapeutic Assessment and the Related Therapy)Bethan Copsey, Alexandra Wright-Hughes, Amanda Farrin, et al.
Environmental Science & Technology|April 3, 2012
Long-term transformation and fate of manufactured ag nanoparticles in a simulated large scale freshwater emergent wetlandGregory V Lowry, Benjamin P Espinasse, Appala Raju Badireddy, et al.
Frontiers in Genetics|April 16, 2019
Identification of a Functional Non-coding Variant in the GABA <sub></sub> Receptor α2 Subunit of the C57BL/6J Mouse Reference Genome: Major Implications for Neuroscience ResearchMegan K Mulligan, Timothy Abreo, Sarah M Neuner, et al.
Leukemia|March 12, 2026
High-risk molecular features may eclipse genomic complexity in predicting chronic lymphocytic leukemia outcomes; UK clinical trial insightsH Parker, L Carr, K Norris, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 10, 2022
Zhx2 Is a Candidate Gene Underlying Oxymorphone Metabolite Brain Concentration Associated with State-Dependent Oxycodone RewardJacob A Beierle, Emily J Yao, Stanley I Goldstein, et al.
Biological Psychiatry|December 5, 2016
Cytoplasmic FMR1-Interacting Protein 2 Is a Major Genetic Factor Underlying Binge EatingStacey L Kirkpatrick, Lisa R Goldberg, Neema Yazdani, et al.
Biorxiv : the Preprint Server for Biology|September 11, 2024
Validation studies and multi-omics analysis of Zhx2 as a candidate quantitative trait gene underlying brain oxycodone metabolite (oxymorphone) levels and behaviorWilliam B Lynch, Sophia A Miracle, Stanley I Goldstein, et al.
Pageof 55

Showing results (511-520 of 548) with videos related to

Sort By:
Pageof 55
Genes, Brain, and Behavior|October 22, 2021
A quantitative trait variant in Gabra2 underlies increased methamphetamine stimulant sensitivityLisa R Goldberg, Emily J Yao, Julia C Kelliher, et al.
G3 (Bethesda, Md.)|July 21, 2019
<i>Cyfip1</i> Haploinsufficiency Increases Compulsive-Like Behavior and Modulates Palatable Food Intake in Mice: Dependence on <i>Cyfip2</i> Genetic Background, Parent-of Origin, and SexRichard K Babbs, Jacob A Beierle, Qiu T Ruan, et al.
Cell Biology and Toxicology|April 24, 2023
GABA<sub>A</sub> receptor-mediated seizure liabilities: a mixed-methods screening approachKonstantina Bampali, Filip Koniuszewski, Florian D Vogel, et al.
Pilot and Feasibility Studies|May 15, 2025
Results of a feasibility study of the FReSH START intervention to improve quality of life and other outcomes in people who repeatedly self-harm (Function REplacement in repeated Self-Harm: Standardising Therapeutic Assessment and the Related Therapy)Bethan Copsey, Alexandra Wright-Hughes, Amanda Farrin, et al.
Environmental Science & Technology|April 3, 2012
Long-term transformation and fate of manufactured ag nanoparticles in a simulated large scale freshwater emergent wetlandGregory V Lowry, Benjamin P Espinasse, Appala Raju Badireddy, et al.
Frontiers in Genetics|April 16, 2019
Identification of a Functional Non-coding Variant in the GABA <sub></sub> Receptor α2 Subunit of the C57BL/6J Mouse Reference Genome: Major Implications for Neuroscience ResearchMegan K Mulligan, Timothy Abreo, Sarah M Neuner, et al.
Leukemia|March 12, 2026
High-risk molecular features may eclipse genomic complexity in predicting chronic lymphocytic leukemia outcomes; UK clinical trial insightsH Parker, L Carr, K Norris, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 10, 2022
Zhx2 Is a Candidate Gene Underlying Oxymorphone Metabolite Brain Concentration Associated with State-Dependent Oxycodone RewardJacob A Beierle, Emily J Yao, Stanley I Goldstein, et al.
Biological Psychiatry|December 5, 2016
Cytoplasmic FMR1-Interacting Protein 2 Is a Major Genetic Factor Underlying Binge EatingStacey L Kirkpatrick, Lisa R Goldberg, Neema Yazdani, et al.
Biorxiv : the Preprint Server for Biology|September 11, 2024
Validation studies and multi-omics analysis of Zhx2 as a candidate quantitative trait gene underlying brain oxycodone metabolite (oxymorphone) levels and behaviorWilliam B Lynch, Sophia A Miracle, Stanley I Goldstein, et al.
Pageof 55